HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs

Vaccine

Volumn 36, Issue 2, 2018, Pages 191-193

  Bonner, Kimberly ^a   Banura, Cecily ^b   Basta, Nicole E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

Adolescents; Africa; Cervical cancer; HPV; Human papillomavirus vaccine; Implementation; LMICs; School based programs; Vaccination programs; Vaccine uptake

Indexed keywords

WART VIRUS VACCINE;

ACCESS TO INFORMATION; CANCER MORTALITY; CANCER SCREENING; COMMUNITY PARTICIPATION; HEALTH CARE ACCESS; HUMAN; INTEGRATED HEALTH CARE SYSTEM; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH MESSAGE; SCHOOL DROPOUT; SCHOOL HEALTH SERVICE; UTERINE CERVIX CANCER; VACCINATION; VULNERABLE POPULATION; ADOLESCENT; CHILD; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH SERVICE; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PROCEDURES; SCHOOL; SEX FACTOR; STANDARDS; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; CHILD; DELIVERY OF HEALTH CARE; FEMALE; HEALTH PLAN IMPLEMENTATION; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SCHOOL HEALTH SERVICES; SCHOOLS; SEX FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 85036503535     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.11.038     Document Type: Note

References (32)

1. Global Burden of Disease Study, Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:10053 (2016), 1545–1602.
2. Chidyaonga-Maseko, F., Chirwa, M.L., Muula, A.S., Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J, 21, 2015, 231.
3. Human papillomavirus vaccines, WHO position paper, May 2017. Wkly Epidemiol Rec 92:19 (2017), 241–268.
4. Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F.X., et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 4:7 (2016), e453–e463.
5. Gallagher, K.E., Howard, N., Kabakama, S., Mounier-Jack, S., Griffiths, U.K., Feletto, M., et al. Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries. PLoS One, 12(6), 2017, e0177773.
6. Global Progress in HPV Vaccination. Last update June 2017. Source: Cervical Cancer Action. < http://www.cervicalcanceraction.org> [accessed November 8th, 2017].
7. Watson-Jones, D., Baisley, K., Ponsiano, R., Lemme, F., Remes, P., Ross, D., et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis 206:5 (2012), 678–686.
8. Tsu, V.D., Cernuschi, T., LaMontagne, D.S., Lessons learned from HPV vaccine delivery in low-resource settings and opportunities for HIV prevention, treatment, and care among adolescents. J Acquir Immune Defic Syndr 66:Suppl 2 (2014), S209–S216.
9. UNESCO IoS. Leaving no one behind: How far on the way to universal primary and secondary education? Policy paper 27/Fact sheet 37; 2016. < http://unesdoc.unesco.org/images/0024/002452/245238E.pdf.> [accessed November 8th, 2017].
10. Bosch-Capblanch, X., Banerjee, K., Burton, A., Unvaccinated children in years of increasing coverage: how many and who are they? Evidence from 96 low- and middle-income countries. Trop Med Int Health 17:6 (2012), 697–710.
11. UNESCO. Reaching the Marginalized: Education for All. UNESCO: Oxford University Press; 2010.
12. Nour, N.M., Health consequences of child marriage in Africa. Emerg Infect Dis 12:11 (2006), 1644–1649.
13. WHO. Guide to Introducing HPV Vaccine into National Immunization Programmes; 2016. < http://apps.who.int/iris/bitstream/10665/253123/1/9789241549769-eng.pdf?ua=1> [accessed November 8th, 2017].
14. WHO. Scaling-Up HPV Vaccine Introduction; 2016. < http://apps.who.int/iris/bitstream/10665/251909/1/9789241511544-eng.pdf?ua=1> [accessed November 8th, 2017].
15. Leon, N., Sanders, D., Van Damme, W., Besada, D., Daviaud, E., Oliphant, N.P., et al. The role of ‘hidden’ community volunteers in community-based health service delivery platforms: examples from sub-Saharan Africa. Glob Health Action, 8, 2015, 27214.
16. Shaghaghi, A., Bhopal, R.S., Sheikh, A., Approaches to recruiting ‘hard-to-reach’ populations into re-search: a review of the literature. Health Promot Perspect 1:2 (2011), 86–94.
17. Siddiqui, N.A., Rabidas, V.N., Sinha, S.K., Verma, R.B., Pandey, K., Singh, V.P., et al. Snowball Vs. house-to-house technique for measuring annual incidence of Kala-azar in the higher Endemic Blocks of Bihar, India: a comparison. PLoS Negl Trop Dis, 10(9), 2016, e0004970.
18. Magnani, R., Sabin, K., Saidel, T., Heckathorn, D., Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19:Suppl 2 (2005), S67–S72.
19. Watson-Jones, D., Mugo, N., Lees, S., Mathai, M., Vusha, S., Ndirangu, G., et al. Access and attitudes to HPV vaccination amongst hard-to-reach populations in Kenya. PLoS One, 10(6), 2015, e0123701.
20. Watson-Jones, D., Tomlin, K., Remes, P., Baisley, K., Ponsiano, R., Soteli, S., et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One, 7(10), 2012, e45231.
21. Kabakama, S., Gallagher, K.E., Howard, N., Mounier-Jack, S., Burchett, H.E., Griffiths, U.K., et al. Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries. BMC Public Health, 16(1), 2016, 834.
22. Jarrett, C., Wilson, R., O'Leary, M., Eckersberger, E., Larson, H.J., Hesitancy SWGoV. Strategies for addressing vaccine hesitancy – a systematic review. Vaccine 33:34 (2015), 4180–4190.
23. Gibson, D.G., Ochieng, B., Kagucia, E.W., Were, J., Hayford, K., Moulton, L.H., et al. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial. Lancet Glob Health 5:4 (2017), e428–e438.
24. Hanson, C.M., Eckert, L., Bloem, P., Cernuschi, T., Gavi HPV programs: application to implementation. Vaccines (Basel) 3:2 (2015), 408–419.
25. Gatera, M., Bhatt, S., Ngabo, F., Utamuliza, M., Sibomana, H., Karema, C., et al. Successive introduction of four new vaccines in Rwanda: high coverage and rapid scale up of Rwanda's expanded immunization program from 2009 to 2013. Vaccine 34:29 (2016), 3420–3426.
26. Binagwaho, A., Wagner, C.M., Gatera, M., Karema, C., Nutt, C.T., Ngabo, F., Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. B World Health Organ 90:8 (2012), 623–628.
27. Ladner, J., Besson, M.H., Audureau, E., Rodrigues, M., Saba, J., Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009–2014. BMC Health Serv Res, 16(1), 2016, 575.
28. Ryman, T., Macauley, R., Nshimirimana, D., Taylor, P., Shimp, L., Wilkins, K., Reaching every district (RED) approach to strengthen routine immunization services: evaluation in the African region, 2005. J Public Health (Oxf) 32:1 (2010), 18–25.
29. Kahn, A.L., Kristensen, D., Rao, R., Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines. Vaccine 35:17 (2017), 2214–2216.
30. Dreyer, G., van der Merwe, F.H., Botha, M.H., Snyman, L.C., Constant, D., Visser, C., et al. School-based human papillomavirus vaccination: an opportunity to increase knowledge about cervical cancer and improve uptake of screening. S Afr Med J 105:11 (2015), 912–916.
31. Snyman, L.C., Dreyer, G., Visser, C., Botha, M.H., van der Merwe, F.H., The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa. S Afr Med J 105:3 (2015), 191–194.
32. Jit, M., Brisson, M., Portnoy, A., Hutubessy, R., Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2:7 (2014), e406–e414.